Video Lectures
State-of-the-industry video lectures by leading urology experts
Latest Videos

TAIPEI, TAIWAN ( - Predisposition for stone formation is a combination of multiple factors, both genetic and environmental. The team at the University of Wisconsin sought to understand the role family history (FH) plays in stone formation, metabolic abnormalities, and risk of stone recurrence. They looked at differences between first, second, and third degree family history, an aspect of the study that makes it unique.

wceDr. Necole Streeper, in her presentation, emphasized that it is important to query family history in all patients in order to set appropriate goals for treatment.

She went on to demonstrate that metabolic abnormalities, most commonly hyperoxaluria, were more prevalent in those with adult onset stone disease, and those with greater than one degree of FH. Interestingly, those patients with a strong FH (> 1 degree) had a significantly higher incidence of stone recurrence. Family history is clearly an important part of the workup of metabolic stone disease.

Presented by Necole M. Streeper, Kristina L. Penniston, and Stephen Y. Nakada at the 32nd World Congress of Endourology & SWL - September 3 - 7, 2014 - Taipei, Taiwan

University of Wisconsin School of Medicine and Public Health, Madison, WI USA

Written by Adam Kaplan, MD, chief resident, Department of Urology, School of Medicine, University of California-Irvine, and medical writer for


Upcoming urology industry events
August 1-5, 2018 / Sheraton Philadelphia Society Hill Hotel
SUFU Research Foundation Resident Preceptorship 2018
August 3-4, 2018 / Hyatt Regency Washington on Capitol Hill
Best of ASCO 2018 - Washington, DC
August 10-11, 2018 / The Palmer House Hilton, Chicago, IL
Best of ASCO 2018 - Chicago, IL
August 28-31, 2018 / ICS 2018
International Continence Society 2018
Print publications focusing on urological cancer treatments through original commentary & articles
Everyday Urology Volume 2 Issue 4

Everyday Urology™ - Oncology Insights

From the Editor

PCAN cover

Prostate Cancer and Prostatic Diseases

From the Editor